Literature DB >> 9635598

Effects of GLP-1 on gastric emptying, antropyloric motility, and transpyloric flow in response to a nonnutrient liquid.

M Anvari1, C A Paterson, E E Daniel, T J McDonald.   

Abstract

Glucagon-like polypeptide 1 (GLP-1) may be a major enterogastrone, slowing gastric emptying when released by intestinal nutrients. In six conscious dogs, we studied the effects of GLP-1, on antropyloric motility, gastric emptying, and transpyloric flow after instillation of 500 ml of saline into the stomach. The meal was given and recordings were started 15 min after intravenous bolus and infusion of either saline or three different doses of GLP-1. Intravenous GLP-1 produced a dose-related retardation of gastric emptying associated with a decrease in the number and volume of flow pulses in comparison to saline. This change in transpyloric flow was associated with an inhibition of antropyloric pressure waves, a stimulation of isolated pyloric pressure waves, and an increase in basal pyloric tone induced by intravenous GLP-1 infusion. Our findings show that GLP-1 has a potent dose-dependent inhibitory effect on transpyloric flow and gastric emptying. This effect is temporally associated with inhibition of antral "pumping" and stimulation of pyloric "braking" mechanisms.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9635598     DOI: 10.1023/a:1018863716749

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  22 in total

1.  Profile of pH, pressure, and potential difference at gastroduodenal junction in man.

Authors:  S Andersson; M I Grossman
Journal:  Gastroenterology       Date:  1965-10       Impact factor: 22.682

2.  Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas.

Authors:  S Mojsov; G C Weir; J F Habener
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

3.  Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.

Authors:  M A Nauck; E Bartels; C Orskov; R Ebert; W Creutzfeldt
Journal:  J Clin Endocrinol Metab       Date:  1993-04       Impact factor: 5.958

Review 4.  Glucagon-like peptide-1, a new hormone of the entero-insular axis.

Authors:  C Orskov
Journal:  Diabetologia       Date:  1992-08       Impact factor: 10.122

5.  Effects of posture on gastric emptying of nonnutrient liquids and antropyloroduodenal motility.

Authors:  M Anvari; M Horowitz; R Fraser; A Maddox; J Myers; J Dent; G G Jamieson
Journal:  Am J Physiol       Date:  1995-05

6.  Gastric emptying and release of incretin hormones after glucose ingestion in humans.

Authors:  J Schirra; M Katschinski; C Weidmann; T Schäfer; U Wank; R Arnold; B Göke
Journal:  J Clin Invest       Date:  1996-01-01       Impact factor: 14.808

7.  Mechanics of pulsatile transpyloric flow in the pig.

Authors:  M Anvari; J Dent; C Malbert; G G Jamieson
Journal:  J Physiol       Date:  1995-10-01       Impact factor: 5.182

8.  Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man.

Authors:  R Eissele; R Göke; S Willemer; H P Harthus; H Vermeer; R Arnold; B Göke
Journal:  Eur J Clin Invest       Date:  1992-04       Impact factor: 4.686

9.  Search for resistances controlling canine gastric emptying of liquid meals.

Authors:  J Miller; G Kauffman; J Elashoff; H Ohashi; D Carter; J H Meyer
Journal:  Am J Physiol       Date:  1981-11

10.  Secretion of glucagon-like peptide-1 and reactive hypoglycemia after partial gastrectomy.

Authors:  J J Andreasen; C Orskov; J J Holst
Journal:  Digestion       Date:  1994       Impact factor: 3.216

View more
  8 in total

1.  Glucagon-like peptide-1 modulates neurally evoked mucosal chloride secretion in guinea pig small intestine in vitro.

Authors:  Sara Baldassano; Guo-Du Wang; Flavia Mulè; Jackie D Wood
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-11-10       Impact factor: 4.052

Review 2.  Glucagon-like peptide 1 (GLP-1).

Authors:  T D Müller; B Finan; S R Bloom; D D'Alessio; D J Drucker; P R Flatt; A Fritsche; F Gribble; H J Grill; J F Habener; J J Holst; W Langhans; J J Meier; M A Nauck; D Perez-Tilve; A Pocai; F Reimann; D A Sandoval; T W Schwartz; R J Seeley; K Stemmer; M Tang-Christensen; S C Woods; R D DiMarchi; M H Tschöp
Journal:  Mol Metab       Date:  2019-09-30       Impact factor: 7.422

3.  Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans.

Authors:  J Schirra; M Nicolaus; R Roggel; M Katschinski; M Storr; H J Woerle; B Göke
Journal:  Gut       Date:  2005-06-28       Impact factor: 23.059

4.  Effects of glucagon-like peptide-1(7-36)amide on antro-pyloro-duodenal motility in the interdigestive state and with duodenal lipid perfusion in humans.

Authors:  J Schirra; P Houck; U Wank; R Arnold; B Göke; M Katschinski
Journal:  Gut       Date:  2000-05       Impact factor: 23.059

5.  Effects of glucagon-like peptide-1(7-36)amide on motility and sensation of the proximal stomach in humans.

Authors:  J Schirra; U Wank; R Arnold; B Göke; M Katschinski
Journal:  Gut       Date:  2002-03       Impact factor: 23.059

Review 6.  Regulation of intestinal lipid and lipoprotein metabolism by the proglucagon-derived peptides glucagon like peptide 1 and glucagon like peptide 2.

Authors:  Erin E Mulvihill
Journal:  Curr Opin Lipidol       Date:  2018-04       Impact factor: 4.776

Review 7.  Advances in the physiology of gastric emptying.

Authors:  Raj K Goyal; Yanmei Guo; Hiroshi Mashimo
Journal:  Neurogastroenterol Motil       Date:  2019-02-10       Impact factor: 3.598

8.  A randomized, double-blind, placebo-controlled, multiple-dose, parallel-group clinical trial to assess the effects of teduglutide on gastric emptying of liquids in healthy subjects.

Authors:  Jolene Kay Berg; Eric H Kim; Benjamin Li; Bo Joelsson; Nader N Youssef
Journal:  BMC Gastroenterol       Date:  2014-02-12       Impact factor: 3.067

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.